Quotient Limited (QTNT) Growth Rates Comparisons to In Vitro & In Vivo Diagnostic Substances Industry, Sector, Market. Sales, Income, EPS
CSIMarket Company Name, Ticker, Customers, else..
 
Quotient Limited  (NASDAQ: QTNT)
 

Quotient Limited Growth Comparisons

Select each growth Category to receive further Information




Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

QTNT Revenue Growth Rate Comparisons Company Industry Sector S&P 500
Y / Y Revenue Growth (Q4 MRQ) -11.03 % 41.61 % 15.09 % 14.5 %
Q / Q Revenue Growth (Q4 MRQ) 3.56 % 19.31 % -1.66 % -1.48 %
Y / Y Revenue Growth (for 12 months ending Q4 TTM) -5.47 % 19.1 % 19.07 % %
Sequential Revenue Growth (for 12 months ending Q4 TTM) -3 % 9.89 % 3.39 % 3 %
Revenue 5 Year Average Growth 11.29 % 18.17 % 8.94 % 9.55 %


QTNT's Growth Comparisons in III. Quarter 2022




Quotient Limited reported sharp sales fall by -11.03% from the same quarter a year ago, in the third quarter 2022, despite the rising Revenue in In Vitro & In Vivo Diagnostic Substances industry by 41.61%, and underperformed the 15.09% Revenue improvement in the Healthcare sector. Although both In Vitro & In Vivo Diagnostic Substances industry and Healthcare sector posted higher gains than 14.5% overall market increase, Quotient Limited was trailing overall market in the third quarter.

Comparing the company's Revenue to the second quarter results, sales were higher by 3.56% . On the yearly basis, average annual sales growth for Quotient Limited is 11.29%, while S & P 500's including only Businesses with the third quarter 2022 earnings, average annual sales growth is 9.55% over the past five years.


Growth Rates of QTNT's Income in the third quarter 2022


QTNT Operating Income Growth Rates Comparisons Company Industry Sector S&P 500
Y / Y Operating Income Change (Q4 MRQ) - 83.05 % 18.01 % 14.73 %
Sequential Operating Income Change (Q4 MRQ) - 281.29 % -4.12 % -12.7 %
Y / Y Operating Income Growth (Q4 TTM) - 73.52 % 66.52 % 59.76 %
Sequential Operating Income Growth (Q4 TTM) - 32.64 % 4.48 % 2.49 %
Operating Income 5 Year Avg. Change - 28.08 % 4.67 % 8.71 %


Income from Cont. Ops. Growth Rates Comparisons Company Industry Sector S&P 500
Y / Y Income from Cont. Ops. Change (Q4 MRQ) - 139.65 % -30.53 % 12.59 %
Sequential Income from Cont. Ops. Change (Q4 MRQ) - 151.08 % -31.69 % 3.2 %
Y / Y Income from Cont. Ops. Change (Q4 TTM) - 4.6 % 65.11 % 63.82 %
Sequential Income from Cont. Ops. Change (Q4 TTM) - 42.09 % -5.77 % 0.34 %
Income from Cont. Ops. 5 Year Avg. Change - 22.86 % 8.32 % 11.88 %

QTNT Net Income Growth Rates Comparisons Company Industry Sector S&P 500
Y / Y Net Income Growth (Q4 MRQ) - 138.24 % -23.23 % 13.8 %
Q / Q Net Income Growth (Q4 MRQ) - 137.59 % -17.86 % 3.68 %
Y / Y Net Income Change (Q4 TTM) - 22.44 % 85.59 % 67.8 %
Sequential Net Income Change (Q4 TTM) - 41.55 % -4.08 % 0.66 %
Net Income 5 Year Avg. Growth - -2.35 % 10.49 % 3.58 %

QTNT's EPS Growth Rates


EPS from Cont. Ops. Growth Rates Comparisons Company Industry Sector S&P 500
Y / Y EPS from Cont. Ops. Change (Q4 MRQ) - 122.23 % -30.53 % 12.59 %
Sequential EPS from Cont. Ops. Change (Q4 MRQ) - 119.47 % -31.69 % 3.2 %
Y / Y EPS from Cont. Ops. Change (Q4 TTM) - 2074.07 % - -
Sequential EPS from Cont. Ops. Change (Q4 TTM) - - -97.74 % 6640.43 %
EPS from Cont. Ops. 5 Year Avg. Growth - 17.61 % 8.32 % 11.88 %



QTNT EPS Net Growth Rates Comparisons Company Industry Sector S&P 500
Y / Y EPS Net Growth (Q4 MRQ) - 120.92 % -23.23 % 11.88 %
Q / Q EPS Net Growth (Q4 MRQ) - 107.68 % -17.86 % 3.68 %
Y / Y EPS Net Change (for 12 months ending Q4 TTM) - - - 40036.37 %
Sequential EPS Net Change (for 12 months ending Q4 TTM) - - - 55.38 %
EPS Net 5 Year Avg. Change - -2.35 % 10.49 % 3.58 %



Quotient Limited reported bottom-line of $ -3.13 in the third quarter, compare to $ 0.00 in the same quarter a year ago. In Vitro & In Vivo Diagnostic Substances industry grew by 120.92%, while Healthcare sector decreased by -23.23%, and overall market improved by 13.8%.

Comparing company's EPS to the second quarter results, income per share were higher by 3.56% . On the yearly basis, average annual income per share growth for Quotient Limited is 11.29%, while S & P 500's including only the businesses with the third quarter 2022 Results, average annual income per share growth is 3.58% over the past five years.

QTNT Cash Flow Growth Rates


Free Cash Flow Growth Rates Company Industry Sector S&P 500
Y / Y Free Cash Flow Change (Q4 MRQ) - -47.36 % -25.22 % -0.56 %
Sequential Free Cash Flow Change (Q4 MRQ) - -13.67 % -40.55 % -42.06 %
Y / Y Free Cash Flow Change (Q4 TTM) - -54.16 % 10.32 % 35.72 %
Sequential Free Cash Flow Change (Q4 TTM) - -20.6 % -1.17 % -3.7 %
Free Cash Flow 5 Year Avg. Change - 2.84 % 6.34 % -24.89 %

Net Cash Flow Growth Rates Company Industry Sector S&P 500
Y / Y Net Cash Flow Change (Q4 MRQ) - -67.14 % - -
Sequential Net Cash Flow Change (Q4 MRQ) - - - -
Y / Y Net Cash Flow Change (Q4 TTM) - - - -85.17 %
Sequential Net Cash Flow Change (Q4 TTM) - - - -60.83 %
Net Cash Flow 5 Year Avg. Change - - -32.87 % 34.23 %

Capital Expenditures Company Industry Sector S&P 500
Y / Y Capital Expenditures Change (Q4 MRQ) 0 % -16.67 % 14.31 % 11.66 %
Sequential Capital Expenditures Change (Q4 MRQ) 113.58 % -0.87 % -29.66 % -22.93 %
Y / Y Capital Expenditures Change (Q4 TTM) -4.08 % 43.65 % 12.61 % 20.71 %
Sequential Capital Expenditures Change (Q4 TTM) 0 % -5.01 % 1.68 % 2.76 %
Capital Expenditures 5 Year Avg. Change - 31.47 % 9.54 % 8.4 %

Note
To view Detail Information & Trends click on Individual Category.
To see Industry, Sector or S&P 500 Performance, click on each Category respectivly, on the top of the Table.

For explanation of terms visit: Glossary
 


• Revenue Y/Y
• Op. Income Y/Y
• Cop. Income Y/Y
• Net Income Y/Y
• Eps Cop. Y/Y
• Eps Net Y/Y
• Free Cash Flow Y/Y
• Cash Flow Y/Y
• Capex Y/Y
• Y/Y Annual




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.